Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 0 | |
Hold | 4 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for Bolt Biotherapeutics Inc have a median target of 1.75, with a high estimate of 2.00 and a low estimate of 1.50. The median estimate represents a 208.75% increase from the last price of 0.5668.
High | 252.9% | 2.00 |
Med | 208.8% | 1.75 |
Low | 164.6% | 1.50 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 19, 2025.
Average growth rate | -10.08% |
Average growth rate | +44.24% |
More ▼
Revenue history & estimates in USD
Average growth rate | +12.19% |
Average growth rate | +279.20% |
More ▼